文献速递免疫规划卫生政策与健康促进

印度轮状病毒疫苗接种的证据基础:现状与未来需求

The evidence base for rotavirus vaccination in India: Current status, future needs.
PubMed 文献 · Vaccine · 2024-11-29

本文通过文献综述和利益相关者咨询,评估印度轮状病毒疫苗现有及即将获得的证据。综述纳入疫苗影响、效果、安全性、卫生经济学、可接受性及操作规划研究,发现证据基础不存在重大缺口,但更多小规模研究仍有价值。印度经验可为亚洲及考虑使用印度产疫苗的国家提供借鉴。

要点

  • 印度两种轮状病毒疫苗已纳入常规免疫规划,决策基于临床试验及疾病负担与卫生经济学研究。
  • 项目引入后开展了三项有效性评估及多项肠套叠相关研究,补充了真实世界使用数据。
  • 综述未发现证据基础存在重大缺口,但更多小规模研究可更全面反映疫苗表现与获益。

核心结论

  • 整体而言,轮状病毒疫苗在印度的证据基础不存在重大缺口,但更多小规模研究将有助于更完整地反映疫苗表现与获益。

研究设计与样本

  • 本文通过文献综述和利益相关者咨询,评估印度轮状病毒疫苗接种现有及即将获得的证据。
  • 综述纳入评估疫苗影响、效果、安全性、卫生经济学、可接受性以及操作与规划研究。

主要发现

  • 项目引入后启动了多项研究,包括三项有效性评估和若干肠套叠相关调查。
  • 来自真实世界使用条件下的疫苗影响、安全性和交付数据将进一步强化和维持免疫规划。
  • 印度经验可为亚洲区域轮状病毒疾病负担仍高但疫苗引入缓慢的国家以及考虑使用印度产疫苗的国家提供借鉴。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rotavirus is a leading cause of severe diarrheal disease in infants and young children worldwide. Vaccination offers the best protection against this disease, and two rotavirus vaccines were developed in India and included in its routine immunization program. The Government of India's decision to adopt this intervention was supported by a solid base of evidence from clinical trials, as well as substantial research regarding rotavirus disease burden and the potential health and economic value of immunization. Following program implementation, multiple studies were initiated, including three evaluations of effectiveness and several investigations regarding intussusception. These additional data regarding vaccine impact, safety, and delivery from post-introduction evaluations in conditions of real-world use will further strengthen and sustain the immunization program. This manuscript evaluates the status of existing and forthcoming evidence regarding rotavirus vaccination in India through a literature review and consultation with relevant stakeholders. Studies evaluating vaccine impact, effectiveness, safety, health economics, and acceptability, as well as operational and programmatic research, were included in the review. Overall, we found that the evidence base did not contain any major gaps. Nevertheless, additional smaller-scale research studies would be valuable in providing a more complete picture of rotavirus vaccine performance and benefit. Documentation of India's experience with rotavirus vaccines may provide lessons learned for other countries in the Asia region, where rotavirus disease burden remains high, yet vaccine adoption has been slow, as well as for countries worldwide that may be considering implementation of the Indian-made rotavirus vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bhat N, Vodicka E, Clifford A, et al. The evidence base for rotavirus vaccination in India: Current status, future needs. Vaccine. 2024. PMID: 39615343. doi:10.1016/j.vaccine.2024.126551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。